查詢結果分析
來源資料
相關文獻
- 腎臟移植的誘導治療
- 小兒的腎臟移植
- Renal Transplantation at a Medical Center in Taiwan
- 處方評估及用藥檢討:腎移植後急性排斥之治療
- 腎移植者生活品質之研究
- Porphyromonas Gingivalis Bacteremia and Subhepatic Abscess after Renal Transplantation: A Case Report
- Malignancy Following Renal Transplantation
- Long-term Results with Pediatric Kidney Transplants in Adult Recipients
- 腎臟移植手術
- 腎臟移植護理
頁籤選單縮合
| 題 名 | 腎臟移植的誘導治療=Induction Therapy in Kidney Transplantation |
|---|---|
| 作 者 | 邱顯富; 吳明儒; 鄭志雄; 徐國雄; | 書刊名 | 腎臟與透析 |
| 卷 期 | 28:1 2016.03[民105.03] |
| 頁 次 | 頁5-9 |
| 專 輯 | 透析治療與腎臟移植之比較專輯 |
| 分類號 | 416.273 |
| 關鍵詞 | 腎臟移植; 誘導治療; 免疫抑制藥物; Kidney transplantation; Induction therapy; Immunosuppressant agents; |
| 語 文 | 中文(Chinese) |
| 中文摘要 | 腎臟移植的免疫抑制治療分為三大項目:誘導治療、維持治療、以及排斥治療。本篇的目的是介紹誘導治療。誘導治療藥物根據作用機轉可分為T細胞消除藥物(T-cell depleting agents)、B細胞與T細胞消除藥物(Band T-cell depleting agents)、非消除性T細胞藥物(nondepleting T-cell agents)。此篇文章將介紹近年內研發的誘導治療藥物,各種藥物的藥理特性、常見的副作用以及如何根據病患的狀況選擇適當的誘導治療藥物。 |
| 英文摘要 | Currently immunosuppressive agents for kidney transplantation can be classified into three categories: induction agents, maintenance therapy, and treatment for rejection. This article is focused on induction therapy. Induction agents can be defined as T-cell depleting, B- and T-cell depleting, and nondepleting T-cell agents. We will focus on the pharmacology, efficacy, major side effects including infection and malignancy, and how to choose an appropriate induction regimen for individualized kidney recipients according to risk and benefit assessment. |
本系統中英文摘要資訊取自各篇刊載內容。